Health
Genetically engineered intestinal organoids reveal potential treatment targets against SARS-CoV-2 – News-Medical.Net
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers…
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers from the Netherlands identified a specific serine protease (TMPRSS2) as an attractive pan-coronavirus therapeutic target. Their exciting findings are available in a study currently available on the bioRxiv* preprint server.
The current coronavirus disease (COVID-19) pandemic, caused by the SARS-CoV-2, has exposed earnest weaknesses…
-
Noosa News15 hours agoHow Lily Steele-Park took her rapist to court and won
-
General21 hours agoRush to buy homes before rate cuts send prices soaring
-
Business18 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Business20 hours agoFord CEO makes stunning prediction about artificial intelligence